We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.5B
AUM Growth
-$613M
Cap. Flow
-$587M
Cap. Flow %
-4.35%
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
203
Reduced
624
Closed
38

Top Buys

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$30.1M
2
ET icon
Energy Transfer Partners
ET
+$24.7M
3
FLJP icon
Franklin FTSE Japan ETF
FLJP
+$11.8M
4
WFC icon
Wells Fargo
WFC
+$9.66M
5
ALKS icon
Alkermes
ALKS
+$8.97M

Top Sells

Rank Stock Value
1
MMP
Magellan Midstream Partners, L.P.
MMP
+$49.8M
2
EPD icon
Enterprise Products Partners
EPD
+$49.1M
3
WES icon
Western Midstream Partners
WES
+$44.8M
4
BPL
Buckeye Partners, L.P.
BPL
+$42.5M
5
EQM
EQM Midstream Partners, LP
EQM
+$28.6M

Sector Composition

Rank Sector Weight
1 Energy 65.41%
2 Financials 7.05%
3 Healthcare 3.6%
4 Consumer Discretionary 3.1%
5 Technology 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYBX
901
DELISTED
Synlogic
SYBX
– –
-4,098
Closed -$467K
SYRS
902
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-8,129
Closed -$743K
GSV
903
DELISTED
Gold Standard Ventures Corp.
GSV
– –
-218,770
Closed -$223K
CALA
904
DELISTED
Calithera Biosciences, Inc
CALA
– –
-4,604
Closed -$621K
ADMS
905
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-66,026
Closed -$469K
FLXN
906
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-91,439
Closed -$1.14M
FPRX
907
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-85,663
Closed -$1.15M
ENT
908
DELISTED
Global Eagle Entertainment Inc.
ENT
– –
-1,323
Closed -$23K
S
909
DELISTED
Sprint Corporation
S
– –
-12,010
Closed -$68K
AVP
910
DELISTED
Avon Products, Inc.
AVP
– –
-46,285
Closed -$136K
ARRY
911
DELISTED
Array Biopharma Inc
ARRY
– –
-382,739
Closed -$9.33M
ELLI
912
DELISTED
Ellie Mae Inc
ELLI
– –
-5,278
Closed -$521K
STMP
913
DELISTED
Stamps.com, Inc.
STMP
– –
-4,499
Closed -$366K
CZR
914
DELISTED
Caesars Entertainment Corporation
CZR
– –
-11,470
Closed -$100K
33 34 35 36
37

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, ALPS Advisors held 914 positions worth $13.5B, down 4.3% from $14.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $587M in Q2 2019, closing 38 positions and reducing 624 holdings. Its most notable exit was Lakefront Biotherapeutics American Depositary Shares, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ALPS Advisors opened a new position in Franklin FTSE Japan ETF worth $11.8M.

  • ALPS Advisors's largest Q2 2019 buy was Franklin FTSE Japan ETF: 491,070 shares worth $11.8M.
  • ALPS Advisors added most to MPLX in Q2 2019, an estimated $30.1M increase.
  • ALPS Advisors's biggest Q2 2019 reduction was Magellan Midstream Partners, L.P., cutting an estimated $49.8M.
  • ALPS Advisors fully exited Lakefront Biotherapeutics American Depositary Shares in Q2 2019, selling an estimated $10.3M.
  • ALPS Advisors's ten largest holdings make up 48% of its $13.5B portfolio in Q2 2019.
  • ALPS Advisors opened 36 new positions and closed 38 in Q2 2019.
  • ALPS Advisors's portfolio value fell 4.3% quarter-over-quarter to $13.5B.

Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.